Farmers Trust Co Lifted Exxon Mobil (XOM) Stake By $752,240; Regenxbio (RGNX) Shorts Increased By 10.84%

October 4, 2017 - By Marie Mckinney

Regenxbio Incorporated (NASDAQ:RGNX) had an increase of 10.84% in short interest. RGNX’s SI was 1.47 million shares in October as released by FINRA. Its up 10.84% from 1.33M shares previously. With 229,800 avg volume, 6 days are for Regenxbio Incorporated (NASDAQ:RGNX)’s short sellers to cover RGNX’s short positions. The SI to Regenxbio Incorporated’s float is 6.1%. It closed at $32 lastly. It is down 51.43% since October 4, 2016 and is uptrending. It has outperformed by 34.73% the S&P500.

Farmers Trust Co increased Exxon Mobil Corp (XOM) stake by 10.79% reported in 2017Q2 SEC filing. Farmers Trust Co acquired 9,403 shares as Exxon Mobil Corp (XOM)’s stock rose 0.21%. The Farmers Trust Co holds 96,561 shares with $7.80 million value, up from 87,158 last quarter. Exxon Mobil Corp now has $346.55 billion valuation. The stock increased 0.04% or $0.03 during the last trading session, reaching $81.79. About 6.27M shares traded. Exxon Mobil Corporation (NYSE:XOM) has declined 9.08% since October 4, 2016 and is downtrending. It has underperformed by 25.78% the S&P500.

Investors sentiment decreased to 0.85 in Q2 2017. Its down 0.04, from 0.89 in 2017Q1. It is negative, as 48 investors sold XOM shares while 822 reduced holdings. 103 funds opened positions while 639 raised stakes. 2.12 billion shares or 0.55% more from 2.10 billion shares in 2017Q1 were reported. Moreover, Amalgamated Bank has 1.17% invested in Exxon Mobil Corporation (NYSE:XOM) for 443,292 shares. Pettee has 5.04% invested in Exxon Mobil Corporation (NYSE:XOM) for 70,352 shares. California-based West Oak Limited Liability Com has invested 0% in Exxon Mobil Corporation (NYSE:XOM). Wallington Asset Mngmt Ltd Liability Co invested in 1.26% or 56,256 shares. Moreover, Cls Invs Llc has 0.03% invested in Exxon Mobil Corporation (NYSE:XOM). 13,133 were accumulated by Peavine Capital Limited Liability Corporation. Calamos Wealth Mgmt Llc has 1.08% invested in Exxon Mobil Corporation (NYSE:XOM) for 94,655 shares. The Nebraska-based Cwm Limited Liability Corp has invested 1.54% in Exxon Mobil Corporation (NYSE:XOM). Kbc Group Nv reported 1.28% of its portfolio in Exxon Mobil Corporation (NYSE:XOM). New York-based Grisanti Capital Lc has invested 0.18% in Exxon Mobil Corporation (NYSE:XOM). Peregrine Asset Advisers Inc invested in 0.55% or 10,698 shares. Savant Cap Ltd Liability reported 1% in Exxon Mobil Corporation (NYSE:XOM). Rocky Mountain Advisers Llc holds 1.02% or 2,661 shares in its portfolio. White Pine Invest owns 14,185 shares. Cap Wealth Planning Ltd accumulated 86,357 shares or 1.12% of the stock.

Among 24 analysts covering Exxon Mobil (NYSE:XOM), 9 have Buy rating, 4 Sell and 11 Hold. Therefore 38% are positive. Exxon Mobil had 66 analyst reports since July 22, 2015 according to SRatingsIntel. As per Friday, March 18, the company rating was maintained by Goldman Sachs. The stock of Exxon Mobil Corporation (NYSE:XOM) has “Hold” rating given on Wednesday, August 19 by Citigroup. Piper Jaffray maintained it with “Hold” rating and $76.0 target in Thursday, August 24 report. The firm has “Hold” rating given on Friday, June 23 by Jefferies. As per Tuesday, June 13, the company rating was maintained by RBC Capital Markets. The firm earned “Underweight” rating on Thursday, September 3 by Barclays Capital. Barclays Capital upgraded Exxon Mobil Corporation (NYSE:XOM) on Tuesday, July 11 to “Overweight” rating. The company was reinitiated on Thursday, July 6 by RBC Capital Markets. The firm has “Hold” rating by RBC Capital Markets given on Tuesday, August 29. Macquarie Research initiated Exxon Mobil Corporation (NYSE:XOM) on Wednesday, September 23 with “Underperform” rating.

Among 4 analysts covering Regenxbio (NASDAQ:RGNX), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Regenxbio had 4 analyst reports since October 12, 2015 according to SRatingsIntel. The rating was initiated by Chardan Capital Markets on Tuesday, October 20 with “Buy”. The stock of Regenxbio Inc (NASDAQ:RGNX) earned “Overweight” rating by Morgan Stanley on Tuesday, October 13. As per Monday, October 12, the company rating was initiated by Piper Jaffray. The rating was initiated by Bank of America with “Buy” on Monday, October 12.

REGENXBIO Inc. is a clinical-stage biotechnology company. The company has market cap of $988.62 million. The Company’s gene therapy product candidates are designed to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. It currently has negative earnings. The Firm develops products candidates across the therapeutic areas of metabolic, neurodegenerative and retinal diseases.